ZIOPHARM Oncology (ZIOP) Cut to Strong Sell at ValuEngine

ZIOPHARM Oncology (ZIOP) Cut to Strong Sell at ValuEngine


Several other research firms also recently weighed in on ZIOP. BidaskClub upgraded shares of ZIOPHARM Oncology from a "strong sell" rating to a "sell" rating in a research note on Thursday, January 4th.



from Biotech News